GeneTex, Inc. started operations in early 1997 in San Antonio,
Texas, and has recently moved to Irvine in California. The company
was founded by three internationally known scientists with
recognized expertise in oncology and infectious diseases and a
businessperson with extensive experience in startup biotechnology
Based on the breadth of experience and expertise of their
scientific founders, the companys initial focus was concentrated on
a portfolio of reagents that met the needs of researchers working
to solve the puzzle of what causes cancer, how cancer can be better
diagnosed, and how aggressive a treatment the doctor and patient
ought to consider.
Their very first products were directed toward breast cancer
research and prognosis. More recently, they have added tools for
scientists studying basic mechanisms common to many forms of
cancer. These research tools include immunological reagents used to
study specific proteins and events involved in the regulation of
the cell cycle and DNA repair and replication.
Their range is extensive and includes over 16,000 high quality
primary antibodies, DNA/RNA/oligos, cell/tissue lysates, isotype
controls, proteins/peptides and research kits.
Search our antibody range here